Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations, Unaudited

v3.24.2.u1
Condensed Consolidated Statements of Operations, Unaudited - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 201,000 158,000 527,000 344,000
Research and development expenses 48,000 47,000 95,000 101,000
Loss from operations (249,000) (205,000) (622,000) (445,000)
Other income (expense)        
Gain on partial forgiveness of PPP note payable 0 0 0 0
Interest and financing expense (84,000) (79,000) (160,000) (173,000)
Net Loss $ (333,000) $ (284,000) $ (782,000) $ (618,000)
Net loss per common share, basic $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Net loss per common share, diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average common shares outstanding, basic 398,506,532 385,223,010 395,939,821 381,838,227
Weighted average common shares outstanding, diluted 398,506,532 385,223,010 395,939,821 381,838,227